- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07723508
BeauSaki Bird's Nest Peptide Efficacy
Efficacy Evaluation of BeauSaki Edible Bird's Best Peptide Product
The goal of this clinical trial is to learn whether BeauSaki Edible Bird's Nest Peptide Product can improve facial skin conditions in healthy adult participants. The main questions it aims to answer are:
Can daily intake of the edible bird's nest peptide product improve facial skin hydration, elasticity, brightness, wrinkles, pores, spots, redness, and skin texture after 8 weeks?
Is the edible bird's nest peptide product well tolerated by participants during the study period?
Researchers will compare participants who take the edible bird's nest peptide capsule with participants who take a placebo capsule without edible bird's nest to see if the product improves facial skin conditions.
Participants will:
- Take one capsule daily for 8 weeks.
- Visit the study site at baseline, week 4, and week 8 for non-invasive facial skin assessments.
- Cleanse their face with water and rest under room temperature conditions for 30 minutes before each skin assessment.
- Complete a brief questionnaire about perceived skin condition and product satisfaction at baseline, week 4, and week 8.
- Have facial photographs taken for skin condition evaluation, with identifiable areas masked before disclosure.
연구 개요
상태
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Taiwan
-
Tainan, Taiwan, 대만, 71710
- Chia Nan University of Pharmacy & Science
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Participants aged over 18 years.
Exclusion Criteria:
- Individuals who are unwilling to participate voluntarily.
- Individuals diagnosed by a physician with skin disease, liver cirrhosis, or chronic renal failure.
- Individuals with known allergies to cosmetics, drugs, or foods.
- Pregnant or breastfeeding individuals.
- Individuals taking medications for chronic diseases.
- Students taught by the principal investigator.
- Individuals unwilling to allow their study-related photographs to be disclosed. Vegetarians.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: BeauSaki Edible Bird's Nest Peptide Group
Participants in this group will take one capsule of BeauSaki Edible Bird's Nest Peptide Product daily for 8 weeks.
|
Participants will take one capsule daily for 8 weeks.
|
|
위약 비교기: Placebo Group
Participants in this group will take one placebo capsule without edible bird's nest daily for 8 weeks.
|
Participants will take one placebo capsule without edible bird's nest daily for 8 weeks.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Facial Skin Analysis Parameters
기간: Baseline, week 4, and week 8
|
VISIA Micro-Analysis Skin Image Analyzer was utilized to measure skin spots, wrinkles, texture, pores, UV spots, brown Spots, red areas, porphyrins. Units: arbitrary units. Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8. |
Baseline, week 4, and week 8
|
|
Skin Moisture
기간: Baseline, week 4, and week 8
|
Skin moisture meter (VapoMeter) was utilized to measure skin moisture.
Units: g/m²h Facial skin condition will be assessed using non-invasive image-based facial skin analysis.
Changes from baseline will be evaluated at week 4 and week 8.
|
Baseline, week 4, and week 8
|
|
Skin elasticity
기간: Baseline, week 4, and week 8
|
Skin elastometer (Soft Plus) was utilized to measure skin elasticity.
Units: arbitrary units.
Facial skin condition will be assessed using non-invasive image-based facial skin analysis.
Changes from baseline will be evaluated at week 4 and week 8.
|
Baseline, week 4, and week 8
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .